Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country.
Diama Bhadra ValeMarcus Tolentino SilvaMichelle Garcia DiscacciatiIlana PolegattoJulio Cesar TeixeiraLuiz Carlos ZeferinoPublished in: PloS one (2021)
Using population-based data, the switch from cytology to hrHPV testing in the cervical cancer screening program of Indaiatuba is less costly and cost-effective than the old cytology program.